QuantCapitol. Congressional Trading Intelligence

Updated 2026-11-05 08:10 UTC · Public disclosure record

DXCMTICKER

Dexcom Inc.

NEUTRAL stock

Congress has disclosed 15 buys and 21 sells of DXCM (Dexcom Inc.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.

Activity Congressional Activity

15
Buy
21
Sell
-6
Net
12
Active politicians

Round-trip watch Still on the books

Members who disclosed buying DXCM and have not disclosed selling, versus their own entry (the most recent disclosed buy). "Open" means no disclosed sale — never "still holds" — and the % is unrealised, on paper. Not investment advice.

MemberEntry (last buy)Entry priceNowvs entryStatus
Rob Bresnahan 2025-05-15 $85.67 $82.29 -3.9% ↩ near entry
Rohit Khanna 2026-05-01 $61.35 $82.29 +34.1% in profit
Michael McCaul 2025-09-22 $69.51 $82.29 +18.4% in profit

Price as of 2026-10-30. Counted open while disclosed buys outnumber disclosed sells; tracks the price, not exact position size (amounts are ranges).

Price & congressional trades
Buy Sell

Fundamentals · FY2026 Valuation

Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for —. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.

P/E
30.97
no sector median
how it's calculated
P/E = price ÷ earnings per share
$82.29 ÷ $2.66 = 30.97
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
P/B
12.1
no sector median
how it's calculated
P/B = price ÷ book value per share
$82.29 ÷ $6.80 = 12.1
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
EV/EBITDA
20.15
no sector median
how it's calculated
EV/EBITDA = (market cap + net debt) ÷ EBITDA — net cash lowers EV
($30.7B − $1.0B net cash) ÷ $1.5B = $29.7B ÷ $1.5B = 20.15
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.

36 trades Recent Congressional Trades

Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.

PoliticianChamberTypeOwnerDateDisclosure lagPrice move
in that
window
AmountScoreSource
Michael McCaul House SELL OCR ◆ insider convergence Spouse 2026-05-07 29 days +19.6% $1K–$15K 9.7 ↗ filing
Rohit Khanna House BUY OCR ◆ insider divergence Child 2026-05-01 38 days +24.9% $1K–$15K 19.9 ↗ filing
Rohit Khanna House BUY OCR ◆ insider divergence Spouse 2026-04-13 21 days -4.9% $1K–$15K 29.0 ↗ filing
Michael McCaul House SELL OCR ◆ insider convergence Spouse 2026-02-04 29 days -0.2% $1K–$15K 7.3 ↗ filing
Rohit Khanna House BUY OCR ◆ insider convergence · moderate Child 2025-12-05 30 days +1.6% $1K–$15K 47.3 ↗ filing
Michael McCaul House SELL OCR ◆ insider divergence · moderate Spouse 2025-10-27 9 days -16.1% $15K–$50K 24.4 ↗ filing
Michael McCaul House BUY OCR ◆ insider convergence · moderate Spouse 2025-09-22 13 days -3.5% $1K–$15K 9.3 ↗ filing
Michael McCaul House BUY OCR ◆ insider divergence Spouse 2025-08-07 29 days +5.4% $1K–$15K 11.6 ↗ filing
Michael McCaul House BUY OCR ◆ insider divergence Spouse 2025-08-04 32 days +5.6% $15K–$50K 30.9 ↗ filing
Michael McCaul House BUY OCR ◆ insider divergence Spouse 2025-07-30 6 days -15.3% $1K–$15K 24.4 ↗ filing
Rob Bresnahan House BUY ◆ insider divergence Self · JP Morgan Brokerage Account 2025-05-15 0 days 0.0% $1K–$15K
0.2% of NW
14.0 ↗ filing
Jefferson Shreve House SELL ◆ insider convergence Self · CRT - Standard Unit Trust 2025-05-12 3 days +0.7% $15K–$50K
<0.1% of NW
48.6 ↗ filing
Rob Bresnahan House SELL ◆ insider convergence · moderate Self · JP Morgan Brokerage Account 2025-04-08 0 days 0.0% $1K–$15K
0.2% of NW
33.6 ↗ filing
Michael McCaul House BUY OCR ◆ insider divergence · moderate Spouse 2025-04-08 27 days +32.3% $50K–$100K 62.1 ↗ filing
Jefferson Shreve House SELL ◆ insider convergence · moderate Self · CRT - Standard Unit Trust 2025-04-07 18 days +16.3% $15K–$50K
<0.1% of NW
84.7 ↗ filing
Michael McCaul House BUY OCR ◆ insider divergence · moderate Spouse 2025-03-13 23 days -12.6% $15K–$50K 94.9 ↗ filing
Rob Bresnahan House BUY ◆ insider divergence · moderate Self · JP Morgan Brokerage Account 2025-02-25 0 days 0.0% $1K–$15K
0.2% of NW
67.0 ↗ filing
Kevin Hern House SELL ◆ insider convergence · moderate Joint · Hern Family Revocable Trust > Brokerage Investment Account 2024-12-31 2 days +0.9% $50K–$100K
0.9% of NW
58.8 ↗ filing
Rohit Khanna House BUY OCR ◆ insider divergence · moderate Child 2024-09-09 23 days — $1K–$15K 75.9 ↗ filing
Josh Gottheimer House SELL ◆ insider convergence Joint · Morgan Stanley - Select UMA Account # 1 2023-09-12 29 days — $1K–$15K
<0.1% of NW
5.5 ↗ filing
Josh Gottheimer House SELL ◆ insider convergence Joint · Morgan Stanley - Select UMA Account # 1 2023-08-21 17 days — $1K–$15K
<0.1% of NW
6.8 ↗ filing
Josh Gottheimer House SELL Joint · Morgan Stanley - Select UMA Account # 1 2022-09-28 7 days — $1K–$15K
<0.1% of NW
8.6 ↗ filing
Kevin Hern House BUY Joint 2021-07-01 1 days — $100K–$250K
2.1% of NW
96.7 ↗ filing
Thomas Suozzi House SELL Self 2021-06-03 27 days — $15K–$50K
0.3% of NW
56.6 ↗ filing
Peter Meijer House SELL Self 2021-02-16 3 days — $1K–$15K 75.9 ↗ filing
Josh Gottheimer House SELL Joint 2020-12-24 12 days — $1K–$15K
<0.1% of NW
19.6 ↗ filing
Gilbert Cisneros House SELL Self 2020-12-22 18 days — $1K–$15K
0.1% of NW
52.4 ↗ filing
Susie Lee House SELL Joint 2020-10-02 30 days — $1K–$15K
0.2% of NW
75.9 ↗ filing
Gilbert Cisneros House BUY Self 2020-09-16 27 days — $1K–$15K
0.1% of NW
75.9 ↗ filing
Josh Gottheimer House SELL Joint 2020-08-13 27 days — $1K–$15K
<0.1% of NW
15.7 ↗ filing
Josh Gottheimer House SELL Joint 2020-05-11 28 days — $1K–$15K
<0.1% of NW
22.3 ↗ filing
Thomas Suozzi House BUY Self 2020-01-10 21 days — $1K–$15K
0.1% of NW
75.9 ↗ filing
Josh Gottheimer House SELL Joint 2019-07-16 29 days — $1K–$15K
<0.1% of NW
52.4 ↗ filing
Bradley Schneider House SELL Spouse 2019-06-20 0 days — $100K–$250K
1.3% of NW
97.8 ↗ filing
Josh Gottheimer House SELL Joint 2019-06-13 27 days — $1K–$15K
<0.1% of NW
86.8 ↗ filing
Thomas MacArthur House SELL Joint 2015-05-27 5 days — $1K–$15K 75.9 ↗ filing

Corporate insiders · SEC Form 4 Insider Activity

What the company's own officers and directors did in DXCM — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →

10
Congress trades with insider convergence
11
…with insider divergence
184
Insider open-market trades

Of the congressional trades in DXCM, 10 coincided with corporate insiders moving the same way within 60 days, and 11 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.

DateInsiderRoleTypeSizeSource
2026-10-27 Stern Sadie C-suite SELL 10b5-1 $202K ↗ EDGAR
2026-10-15 Brown Michael Jon C-suite SELL 10b5-1 $145K ↗ EDGAR
2026-09-28 Stern Sadie C-suite SELL 10b5-1 $221K ↗ EDGAR
2026-09-15 Brown Michael Jon C-suite SELL 10b5-1 $143K ↗ EDGAR
2026-09-15 AUGUSTINOS NICHOLAS Director SELL 10b5-1 $550K ↗ EDGAR
2026-09-14 AUGUSTINOS NICHOLAS Director SELL 10b5-1 $130K ↗ EDGAR
2026-09-10 Sylvain Jereme M C-suite SELL 10b5-1 $303K ↗ EDGAR
2026-08-27 Stern Sadie C-suite SELL 10b5-1 $227K ↗ EDGAR
2026-08-20 SAYER KEVIN R Director SELL 10b5-1 $1.7M ↗ EDGAR
2026-08-20 SAYER KEVIN R Director SELL 10b5-1 $667K ↗ EDGAR
2026-08-20 SAYER KEVIN R Director SELL 10b5-1 $9K ↗ EDGAR
2026-08-14 Brown Michael Jon C-suite SELL 10b5-1 $156K ↗ EDGAR
2026-08-12 Heller Bridgette P Director SELL 10b5-1 $89K ↗ EDGAR
2026-08-03 FOLETTA MARK G Director SELL 10b5-1 $171K ↗ EDGAR
2026-07-31 FOLETTA MARK G Director SELL 10b5-1 $160K ↗ EDGAR
2026-07-20 SAYER KEVIN R Director SELL 10b5-1 $2.0M ↗ EDGAR
2026-07-15 Brown Michael Jon C-suite SELL 10b5-1 $127K ↗ EDGAR
2026-07-06 SAYER KEVIN R Director SELL 10b5-1 $1.9M ↗ EDGAR
2026-06-15 FOLETTA MARK G Director SELL 10b5-1 $282K ↗ EDGAR
2026-06-15 FOLETTA MARK G Director SELL 10b5-1 $15K ↗ EDGAR
2026-06-15 Brown Michael Jon C-suite SELL 10b5-1 $128K ↗ EDGAR
2026-06-04 Coleman Jon C-suite SELL 10b5-1 $364K ↗ EDGAR
2026-06-03 Coleman Jon C-suite SELL 10b5-1 $359K ↗ EDGAR
2026-05-21 SAYER KEVIN R Director SELL 10b5-1 $1.9M ↗ EDGAR
2026-05-15 Brown Michael Jon C-suite SELL 10b5-1 $102K ↗ EDGAR

Combined timeline — Congress & insiders

Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.

DateWhoTypeSize
◆ insider 2026-10-27 Stern Sadie C-suite 10b5-1 SELL $202K
◆ insider 2026-10-15 Brown Michael Jon C-suite 10b5-1 SELL $145K
◆ insider 2026-09-28 Stern Sadie C-suite 10b5-1 SELL $221K
◆ insider 2026-09-15 Brown Michael Jon C-suite 10b5-1 SELL $143K
◆ insider 2026-09-15 AUGUSTINOS NICHOLAS Director 10b5-1 SELL $550K
◆ insider 2026-09-14 AUGUSTINOS NICHOLAS Director 10b5-1 SELL $130K
◆ insider 2026-09-10 Sylvain Jereme M C-suite 10b5-1 SELL $303K
◆ insider 2026-08-27 Stern Sadie C-suite 10b5-1 SELL $227K
◆ insider 2026-08-20 SAYER KEVIN R Director 10b5-1 SELL $1.7M
◆ insider 2026-08-20 SAYER KEVIN R Director 10b5-1 SELL $667K
◆ insider 2026-08-20 SAYER KEVIN R Director 10b5-1 SELL $9K
◆ insider 2026-08-14 Brown Michael Jon C-suite 10b5-1 SELL $156K
◆ insider 2026-08-12 Heller Bridgette P Director 10b5-1 SELL $89K
◆ insider 2026-08-03 FOLETTA MARK G Director 10b5-1 SELL $171K
◆ insider 2026-07-31 FOLETTA MARK G Director 10b5-1 SELL $160K
◆ insider 2026-07-20 SAYER KEVIN R Director 10b5-1 SELL $2.0M
◆ insider 2026-07-15 Brown Michael Jon C-suite 10b5-1 SELL $127K
◆ insider 2026-07-06 SAYER KEVIN R Director 10b5-1 SELL $1.9M
◆ insider 2026-06-15 FOLETTA MARK G Director 10b5-1 SELL $282K
◆ insider 2026-06-15 FOLETTA MARK G Director 10b5-1 SELL $15K
◆ insider 2026-06-15 Brown Michael Jon C-suite 10b5-1 SELL $128K
◆ insider 2026-06-04 Coleman Jon C-suite 10b5-1 SELL $364K
◆ insider 2026-06-03 Coleman Jon C-suite 10b5-1 SELL $359K
◆ insider 2026-05-21 SAYER KEVIN R Director 10b5-1 SELL $1.9M

FAQ Common questions

How much has Congress traded DXCM?

15 disclosed buys and 21 sells of DXCM (Dexcom Inc.) appear in official congressional financial disclosures.

Is it legal for members of Congress to trade DXCM?

Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.

Where does this data come from?

Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.

About this data. Sourced from official House Clerk and Senate eFD financial disclosures (Senate via a maintained community mirror — see project documentation). Transaction amounts are reported as ranges, not exact figures. Interest scores, consensus labels, and backtested performance are proprietary analytical calculations based on public data and are not investment advice. Backtested performance is a hypothetical simulation, not actual portfolio performance.